SCP
CRL icon

Sandhill Capital Partners’s Charles River Laboratories CRL Stock Holding History

Sandhill Capital Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-808
Closed -$219K – 91
2024
Q1 		$219K Buy
+808
New +$193K 0.02% 84
2022
Q2 		– Sell
-809
Closed -$230K – 93
2022
Q1 		$230K Hold
809
– – 0.02% 76
2021
Q4 		$305K Hold
809
– – 0.02% 78
2021
Q3 		$334K Sell
809
-2
-0.2% -$831 0.03% 78
2021
Q2 		$300K Buy
+811
New +$271K 0.02% 78

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Sandhill Capital Partners's CRL Position: Q2 2024 in Review

Sandhill Capital Partners sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 808 shares — an estimated $219K sold.

Sandhill Capital Partners first reported a position in CRL in Q2 2021 and held it in 5 quarters. The position peaked at $334K in Q3 2021. 664 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Sandhill Capital Partners reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • Sandhill Capital Partners sold 808 Charles River Laboratories shares in Q2 2024, an estimated $219K.
  • Sandhill Capital Partners first reported a position in Charles River Laboratories in Q2 2021 and held it in 5 quarters.
  • Sandhill Capital Partners's Charles River Laboratories position peaked at $334K in Q3 2021.
  • 664 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Sandhill Capital Partners's 13F filing for Q2 2024, filed 13 Aug 2024.